Based on an association of 4 bioavailable ingredients (flavanols from French grape, SuperOxide Dismutase (SOD) from melon, zinc and vitamin C), SkinAX2® has been clinically tested in an 8 weeks interventional clinical trial. Results: skin luminosity improved by 25%, regulation of skin coloration, improvement of the complexion homogeneity, global skin imperfections decrease of 15%.